Not all itches go away with a simple scratch. Roughly 15 percent of people suffer relentless, long-term itch, often caused by diseases and medications. Now, researchers have identified a hormone in mice that delivers itchy sensations to neurons in the spinal cord, which then relays the signal to the brain. The discovery could point to treatments for people who suffer from chronic itch caused by disease or medication.
Scientists have known for a long time that sensory neurons called TRPV1 cells can detect itchy substances on the skin, said Mark Hoon, a neuroscientist at National Institute of Dental and Craniofacial Research in Bethesda, Md. But it wasn’t clear whether the neurons that respond to itch are unique, or if itch might simply be low-grade pain. That’s made it difficult to develop treatments that target itch without affecting other sensory systems, Hoon said.
While analyzing molecules excreted by TRPV1 cells in search of anything that might be itch-specific, Hoon and his colleagues came across a small group of the neurons that produce natriuretic polypeptide b, a hormone that regulates heart function and can also act as a neurotransmitter. Nppb is prominently expressed in a small subset of dorsal root ganglia neurons but is dramatically decreased in sensory ganglia from TRPV1 cells.
“We wondered what those cells were doing,” Hoon said.
To find out, the team genetically modified mice to block production of Nppb in TRPV1 neurons, then injected the skin on their shoulders with a range of itch-inducing compounds. Normally, these substances make mice scratch nonstop, but the knockout mice hardly scratched themselves at all after the injection, showing that Nppb was required to produce the sensation of itch, the authors reported online Thursday in the journal Science. No other sensory systems appeared to be affected in the knockout mice, Hoon says.
Next, the researchers looked to the dorsal horn of the spinal cord, where signals from peripheral nerves are routed to the brain, and found the receptors for Nppb in a group of neurons that release a molecule called gastrin-releasing peptide. GRP was previously thought to be the original molecular trigger for itch, Hoon said – but it’s now clear that Nppb-releasing TRPV1 neurons are the first trigger in transmitting itch.
New therapies for humans that safely block Nppb activity are still be a long way off, however. Although the Nppb-knockout mice lived a normal lifespan, when the researchers killed the receptor cells in the spinal cord, the mice died prematurely, suggesting that it could be dangerous to try in humans, Hoon said.
The Charlotte Observer welcomes your comments on news of the day. The more voices engaged in conversation, the better for us all, but do keep it civil. Please refrain from profanity, obscenity, spam, name-calling or attacking others for their views.
Have a news tip? You can send it to a local news editor; email email@example.com to send us your tip - or - consider joining the Public Insight Network and become a source for The Charlotte Observer.Read moreRead less